Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Given Average Recommendation of “Moderate Buy” by Brokerages

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has been assigned an average recommendation of “Moderate Buy” from the twelve research firms that are currently covering the stock, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $10.5556.

Several analysts have recently commented on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Thursday, July 2nd. Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $10.00 to $11.00 in a research report on Friday, May 15th. BMO Capital Markets lowered their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, March 20th. Barclays increased their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a research report on Thursday. Finally, Royal Bank Of Canada raised Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a report on Wednesday, June 3rd.

Aveanna Healthcare Stock Performance

Shares of AVAH stock traded down $0.12 during mid-day trading on Friday, reaching $9.70. The stock had a trading volume of 1,745,874 shares, compared to its average volume of 2,285,978. Aveanna Healthcare has a 1-year low of $3.73 and a 1-year high of $10.32. The firm has a market cap of $2.11 billion, a price-to-earnings ratio of 8.22, a PEG ratio of 0.96 and a beta of 1.89. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 5.35. The business’s fifty day moving average is $7.66 and its 200-day moving average is $7.59.

Aveanna Healthcare (NASDAQ:AVAH) last issued its earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The firm had revenue of $647.91 million for the quarter, compared to analyst estimates of $613.22 million. The company’s quarterly revenue was up 15.9% on a year-over-year basis. On average, research analysts forecast that Aveanna Healthcare will post 0.68 earnings per share for the current year.

Insider Buying and Selling

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 7,000,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total value of $43,680,000.00. Following the sale, the insider owned 252,899 shares in the company, valued at approximately $1,578,089.76. This represents a 96.51% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 5,842,240 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $6.24, for a total transaction of $36,455,577.60. Following the sale, the insider directly owned 13,450,547 shares in the company, valued at $83,931,413.28. The trade was a 30.28% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 31,305,664 shares of company stock valued at $215,555,910 in the last ninety days. Insiders own 5.30% of the company’s stock.

Institutional Trading of Aveanna Healthcare

A number of hedge funds have recently added to or reduced their stakes in AVAH. Vanguard Group Inc. lifted its holdings in Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock worth $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Algert Global LLC raised its stake in shares of Aveanna Healthcare by 120.1% in the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock valued at $9,070,000 after acquiring an additional 557,898 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in Aveanna Healthcare by 16.4% in the first quarter. Assenagon Asset Management S.A. now owns 951,594 shares of the company’s stock valued at $6,128,000 after purchasing an additional 134,043 shares during the period. UBS Group AG boosted its holdings in Aveanna Healthcare by 149.4% in the fourth quarter. UBS Group AG now owns 394,182 shares of the company’s stock valued at $3,220,000 after purchasing an additional 236,152 shares during the period. Finally, Precision Wealth Strategies LLC acquired a new position in Aveanna Healthcare during the 4th quarter worth $1,075,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.